计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| L171714-25mg |
25mg |
现货 ![]() |
| |
| L171714-100mg |
100mg |
现货 ![]() |
| |
| L171714-250mg |
250mg |
现货 ![]() |
| |
| L171714-1g |
1g |
现货 ![]() |
|
| 英文别名 | EN300-20605731 | 7-hydroxy-2-methyl-3-phenoxy-chromone | s3714 | A900838 | Q23044263 | N-(2-(1-benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carbonyl)-3-(methanesulfonyl)-L-phenylalanine | (2S)-2-{[2-(1-benzofuran-6-carbonyl)-5,7-di |
|---|---|
| 规格或纯度 | Moligand™, ≥97% |
| 英文名称 | Lifitegrast |
| 生化机理 | LFA-1(淋巴细胞功能相关抗原-1)拮抗剂,用于治疗眼部血管并发症。Lifitegrast \ xa0是一种新型T细胞整合素拮抗剂,旨在模拟ICAM-1的结合表位。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 拮抗剂 |
| 作用机制 | Integrin alpha-L/beta-2 (LFA-1) 拮抗剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
Lifitegrast (SAR1118)是一种新型的integrin拮抗剂,抑制参与DED病理形成中的特定的T细胞介导的炎症途径。 LFA-1 (lymphocyte function-associated antigen-1) antagonist. |
| 纯度 | ≥97% |
| ALogP | 4.7 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504766848 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | (2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid |
| INCHI | 1S/C29H24Cl2N2O7S/c1-41(38,39)20-4-2-3-16(11-20)12-23(29(36)37)32-27(34)25-22(30)13-19-15-33(9-7-21(19)26(25)31)28(35)18-6-5-17-8-10-40-24(17)14-18/h2-6,8,10-11,13-14,23H,7,9,12,15H2,1H3,(H,32,34)(H,36,37)/t23-/m0/s1 |
| InChi Key | JFOZKMSJYSPYLN-QHCPKHFHSA-N |
| Smiles | CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl |
| Isomeric SMILES | CS(=O)(=O)C1=CC=CC(=C1)C[C@@H](C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl |
| 分子量 | 615.48 |
| Reaxy-Rn | 42812549 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=42812549&ln= |
| 分子量 | 615.500 g/mol |
|---|---|
| XLogP3 | 4.700 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 7 |
| 可旋转键计数Rotatable Bond Count | 7 |
| 精确质量Exact Mass | 614.068 Da |
| 单同位素质量Monoisotopic Mass | 614.068 Da |
| 拓扑极表面积Topological Polar Surface Area | 142.000 Ų |
| 重原子数Heavy Atom Count | 41 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 1100.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 1 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS08 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H361: 怀疑破坏生育力或未出生的孩子 |
| 预防措施声明 |
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P405: 密闭存放 P501: 将内容物/容器处理到。。。 P203: 使用前,获取、阅读并遵守所有安全说明。 P318: 如果暴露或担心,请就医。 |
| 1. Giblin PA, Lemieux RM. (2006) LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based therapeutics.. Curr Pharm Des, 12 (22): (2771-95). [PMID:16918410] |
| 2. Lam H, Bleiden L, de Paiva CS, Farley W, Stern ME, Pflugfelder SC. (2009) Tear cytokine profiles in dysfunctional tear syndrome.. Am J Ophthalmol, 147 (2): (198-205. e1). [PMID:18992869] |
| 3. Murphy CJ, Bentley E, Miller PE, McIntyre K, Leatherberry G, Dubielzig R, Giuliano E, Moore CP, Phillips TE, Smith PB et al.. (2011) The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs.. Invest Ophthalmol Vis Sci, 52 (6): (3174-80). [PMID:21330663] |
| 4. Kapp TG, Rechenmacher F, Sobahi TR, Kessler H. (2013) Integrin modulators: a patent review.. Expert Opin Ther Pat, 23 (10): (1273-95). [PMID:24050747] |
| 5. Sheppard JD, Torkildsen GL, Lonsdale JD, D'Ambrosio Jr FA, McLaurin EB, Eiferman RA, Kennedy KS, Semba CP, OPUS-1 Study Group. (2014) Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.. Ophthalmology, 121 (2): (475-83). [PMID:24289915] |
| 6. Zhong M, Gadek TR, Bui M, Shen W, Burnier J, Barr KJ, Hanan EJ, Oslob JD, Yu CH, Zhu J et al.. (2012) Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye.. ACS Med Chem Lett, 3 (3): (203-6). [PMID:24900456] |
| 7. A-González N, Castrillo A. (2011) Liver X receptors as regulators of macrophage inflammatory and metabolic pathways.. Biochim Biophys Acta, 1812 (8): (982-94). [PMID:21193033] |
| 8. Xin Meng, Ye Wang. (2021) Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor. MOLECULES, 26 (23): (7326). [PMID:34885905] [10.3390/molecules26237326] |
| 9. Han Sun, Xu Pang, Jian-Rui Li, Hu Li, Mei Tang, Tao Zhang, Li-Yan Yu, Zong-Gen Peng. (2024) Isoechinulin B, a natural product from Antarctic fungus, attenuates acute liver injury by inhibiting excessive cell adhesion. EUROPEAN JOURNAL OF PHARMACOLOGY, (177065). [PMID:39427860] [10.1016/j.ejphar.2024.177065] |